Top in endocrinology: CVD risk in diabetes, bone strength during adolescence

A recent study demonstrated that lower fat intake and higher fiber and vitamin C intake led to a lower long-term risk for CVD in adults newly diagnosed with type 2 diabetes. It was the top story in endocrinology last week.

Another top story included data that showed adolescent boys who engaged in high-impact exercise had greater bone strength than boys who did not exercise.

Read these and more top stories in endocrinology below:

Eat less fat, more fiber and vitamin C to reduce CVD risk in diabetes

Adults newly diagnosed with type 2 diabetes had a lower long-term risk for CVD if they had lower fat intake and higher intake of fiber and vitamin C, according to data published in Diabetic Medicine. Read more.

High-impact exercise builds bone strength in boys during adolescence

Boys who engaged in high-impact exercise in early adolescence experienced greater gains in bone mineral density compared with boys who reported no exercise practice, data from a population-based study show. Read more.

Thyroidectomy tied to CV complications after cancer diagnosis

Adults with differentiated thyroid cancer who undergo thyroidectomy are at increased risks for atrial fibrillation, cardiovascular disease, increased heart rate and left ventricular mass development, data from a review show. Read more.

Intermittent very low-calorie diet lowers glucose levels in adults with obesity, diabetes

Adults with obesity and type 2 diabetes improved glucose levels after eating a very low-calorie diet either 2 or 4 days per week, according to study findings published in the Journal of Diabetes Investigation. Read more.

Human, exendin-based GLP-1 receptor agonists similarly reduce CV, renal risk in diabetes

A pooled study assessing trials of eight GLP-1 receptor agonists showed all reduce risk for a combined endpoint of major adverse cardiovascular events, regardless of structural homology to human GLP-1, as well as individual cardiovascular components. Read more.